Much has been said about Lindsay Rosenwald’s notable accomplishments as a biotechnology entrepreneur. A highly distinguished and respected name in the financial and medical worlds, Dr. Rosenwald will continue to be a prime mover and shaker in these industries to elevate the level of health and enhance the life of patients and largely, of the entire human race. But beyond his financial success as an investor, few have been written about his charitable deeds, and that he is also busy extending his assistance to more people as a noble philanthropist.
One recipient of his generous kindness was the Sh’or Yoshuv Institute, a well-known Rabbinical College that has been the leader of Judaic education for forty years. This congregation provides premier spiritual and educational resources to more than a thousand of families in the Far Rockaway and Five Towns districts. Dr. Lindsay Rosenwald and his wife are very close friends to the Institute. This organization of Jewish communities has numerous outreach programs and is committed to charity. And when the said Institute encountered a serious financial crisis, Dr. Rosenwald selflessly offered to cover the entire budgetary deficit.
Stories of Dr. Lindsay Rosenwald’s abound yet he did not do those charitable activities publicly. He does not want the limelight and did not seek to be commended for his generosity, but he is always willing to do everything within his capability to help out especially if it is intended for education. Dr. Rosenwald and his family also promote the advancement of education and constantly invest in that sector as well.
The Rosenwald Foundation is also a representation of his endless benevolence. A non-profit organization which has given millions of dollars to support many scientific and medical education institutions, this is Lindsay Rosenwald’s way to widen his reach to more researchers and scientists who need funding to carry on with their search and development of more life guarding drugs.
Dr. Lindsay Rosenwald is an investment banker, venture capitalist and hedge fund manager. He has been a Wall Street biotech businessman for over 20 years, founding, financing and recapitalizing numerous of both public and private biotechnology and life-sciences companies.
Comments